Overview

An International, Multicenter, Randomized, Double-blind, Double-dummy, Two-way, Parallel Group, Controlled Study to Compare the Efficacy and Safety of Intravenous and Oral Nemonoxacin Versus Tavanic® in Adult Patients With Community-acquired Pneumo

Status:
Completed

Trial end date:
2017-12-26

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to evaluate the clinical efficacy of treatment with Nemonoxacin compared with Tavanic® in patients with community-acquired pneumonia (CAP).

Phase:

Phase 3

Details

Lead Sponsor:

R-Pharm

Collaborator:

OCT Clinical Trials

Treatments:

Levofloxacin
Ofloxacin
Pharmaceutical Solutions